Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
33.02M | 32.31M | 30.00M | 27.03M | 24.60M | 23.39M | Gross Profit |
16.82M | 17.93M | 12.14M | 10.51M | 9.04M | 9.17M | EBIT |
1.80M | 1.41M | 1.14M | 612.00K | -938.00K | -238.00K | EBITDA |
4.54M | 2.42M | 4.62M | 3.86M | 2.90M | 1.54M | Net Income Common Stockholders |
1.50M | 1.18M | 1.06M | 383.00K | -1.13M | -1.49M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
6.36M | 4.26M | 5.04M | 5.62M | 7.28M | 5.11M | Total Assets |
21.96M | 38.55M | 39.62M | 35.12M | 37.18M | 35.27M | Total Debt |
0.00 | 4.58M | 3.67M | 4.12M | 5.68M | 4.52M | Net Debt |
-6.36M | 325.00K | -1.37M | -1.51M | -1.60M | -590.00K | Total Liabilities |
8.77M | 20.25M | 22.27M | 19.61M | 22.45M | 19.82M | Stockholders Equity |
13.19M | 18.31M | 17.83M | 15.99M | 15.21M | 15.93M |
Cash Flow | Free Cash Flow | ||||
4.34M | 4.32M | 1.30M | -74.00K | 1.98M | -1.58M | Operating Cash Flow |
4.51M | 4.38M | 5.32M | 2.54M | 4.29M | 741.00K | Investing Cash Flow |
-4.99M | -5.36M | -4.02M | -2.61M | -2.31M | -4.47M | Financing Cash Flow |
488.00K | 376.00K | -1.98M | -1.51M | 1.07M | 2.55M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | £100.25M | 16.29 | 51.83% | ― | 64.99% | 270.77% | |
71 Outperform | £89.47M | 16.26 | 10.98% | 1.63% | 4.97% | 3.63% | |
66 Neutral | £71.52M | 100.34 | 3.66% | 5.59% | -6.29% | -86.64% | |
65 Neutral | £63.59M | 16.05 | 14.55% | 2.07% | 26.05% | 7.09% | |
62 Neutral | $11.90B | 10.64 | -7.50% | 2.90% | 7.41% | -8.19% | |
60 Neutral | £52.87M | 316.67 | 0.88% | ― | 4.80% | 350.00% | |
47 Neutral | £90.98M | ― | -22.14% | ― | -14.88% | 88.86% |